AAAAAA
Results: 1-25/27
Authors:
Lee, SC
Schwarcz, R
Citation: Sc. Lee et R. Schwarcz, Excitotoxic injury stimulates pro-drug-induced 7-chlorokynurenate formation in the rat striatum in vivo, NEUROSCI L, 304(3), 2001, pp. 185-188
Authors:
Hilmas, C
Pereira, EFR
Alkondon, M
Rassoulpour, A
Schwarcz, R
Albuquerque, EX
Citation: C. Hilmas et al., The brain metabolite kynurenic acid inhibits alpha 7 nicotinic receptor activity and increases non-alpha 7 nicotinic receptor expression: Physiopathological implications, J NEUROSC, 21(19), 2001, pp. 7463-7473
Authors:
Ceresoli-Borroni, G
Schwarcz, R
Citation: G. Ceresoli-borroni et R. Schwarcz, Neonatal asphyxia in rats: Acute effects on cerebral kynurenine metabolism, PEDIAT RES, 50(2), 2001, pp. 231-235
Authors:
Denslow, MJ
Eid, T
Du, F
Schwarcz, R
Lothman, EW
Steward, O
Citation: Mj. Denslow et al., Disruption of inhibition in area CA1 of the hippocampus in a rat model of temporal lobe epilepsy, J NEUROPHYS, 86(5), 2001, pp. 2231-2245
Authors:
Guidetti, P
Charles, V
Chen, EY
Reddy, PH
Kordower, JH
Whetsell, WO
Schwarcz, R
Tagle, DA
Citation: P. Guidetti et al., Early degenerative changes in transgenic mice expressing mutant huntingtininvolve dendritic abnormalities but no impairment of mitochondrial energy production, EXP NEUROL, 169(2), 2001, pp. 340-350
Authors:
Lehrmann, E
Molinari, A
Speciale, C
Schwarcz, R
Citation: E. Lehrmann et al., Immunohistochemical visualization of newly formed quinolinate in the normal and excitotoxically lesioned rat striatum, EXP BRAIN R, 141(3), 2001, pp. 389-397
Authors:
Eid, T
Du, F
Schwarcz, R
Citation: T. Eid et al., Ibotenate injections into the pre- and parasubiculum provide partial protection against kainate-induced epileptic damage in layer III of rat entorhinal cortex, EPILEPSIA, 42(7), 2001, pp. 817-824
Authors:
Schwarcz, R
Rassoulpour, A
Wu, HQ
Medoff, D
Tamminga, CA
Roberts, RC
Citation: R. Schwarcz et al., Increased cortical kynurenate content in schizophrenia, BIOL PSYCHI, 50(7), 2001, pp. 521-530
Authors:
Scharfman, HE
Goodman, JH
Schwarcz, R
Citation: He. Scharfman et al., Electrophysiological effects of exogenous and endogenous kynurenic acid inthe rat brain: studies in vivo and in vitro, AMINO ACIDS, 19(1), 2000, pp. 283-297
Authors:
Ceresoli-Borroni, G
Schwarcz, R
Citation: G. Ceresoli-borroni et R. Schwarcz, Perinatal kynurenine pathway metabolism in the normal and asphyctic rat brain, AMINO ACIDS, 19(1), 2000, pp. 311-323
Authors:
Wu, HQ
Guidetti, P
Goodman, JH
Varasi, M
Ceresoli-Borroni, G
Speciale, C
Scharfman, HE
Schwarcz, R
Citation: Hq. Wu et al., Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo, NEUROSCIENC, 97(2), 2000, pp. 243-251
Authors:
Guidetti, P
Reddy, PH
Tagle, DA
Schwarcz, R
Citation: P. Guidetti et al., Early kynurenergic impairment in Huntington's Disease and in a transgenic animal model, NEUROSCI L, 283(3), 2000, pp. 233-235
Authors:
Schwarcz, R
Fescina, R
Citation: R. Schwarcz et R. Fescina, Maternal mortality in Latin America and the Caribbean, LANCET, 356, 2000, pp. S11-S11
Authors:
Battaglia, G
Rassoulpour, A
Wu, HQ
Hodgkins, PS
Kiss, C
Nicoletti, F
Schwarcz, R
Citation: G. Battaglia et al., Some metabotropic glutamate receptor ligands reduce kynurenate synthesis in rats by intracellular inhibition of kynurenine aminotransferase II, J NEUROCHEM, 75(5), 2000, pp. 2051-2060
Authors:
Guidetti, P
Wu, HQ
Schwarcz, R
Citation: P. Guidetti et al., In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum, EXP NEUROL, 163(1), 2000, pp. 123-130
Authors:
Wu, HQ
Lee, SC
Schwarcz, R
Citation: Hq. Wu et al., Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus, EUR J PHARM, 390(3), 2000, pp. 267-274
Authors:
Coyle, JT
Schwarcz, R
Citation: Jt. Coyle et R. Schwarcz, Mind glue - Implications of glial cell biology for psychiatry, ARCH G PSYC, 57(1), 2000, pp. 90-93
Authors:
Guidetti, P
Schwarcz, R
Citation: P. Guidetti et R. Schwarcz, 3-hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum, EUR J NEURO, 11(11), 1999, pp. 3857-3863
Authors:
Scharfman, HE
Hodgkins, PS
Lee, SC
Schwarcz, R
Citation: He. Scharfman et al., Quantitative differences in the effects of de novo produced and exogenous kynurenic acid in rat brain slices, NEUROSCI L, 274(2), 1999, pp. 111-114
Authors:
Ceresoli-Borroni, G
Guidetti, P
Schwarcz, R
Citation: G. Ceresoli-borroni et al., Acute and chronic changes in kynurenate formation following an intrastriatal quinolinate injection in rats, J NEURAL TR, 106(3-4), 1999, pp. 229-242
Authors:
Linderberg, M
Hellberg, S
Bjork, S
Gotthammar, B
Hogberg, T
Persson, K
Schwarcz, R
Luthman, J
Johansson, R
Citation: M. Linderberg et al., Synthesis and QSAR of substituted 3-hydroxyranthranilic acid derivatives as inhibitors of 3-hydroxyanthranilic acid dioxygenase (3-HAO), EUR J MED C, 34(9), 1999, pp. 729-744
Authors:
Hodgkins, PS
Wu, HQ
Zielke, HR
Schwarcz, R
Citation: Ps. Hodgkins et al., 2-Oxoacids regulate kynurenic acid production in the rat brain: Studies invitro and in vivo, J NEUROCHEM, 72(2), 1999, pp. 643-651
Authors:
Eid, T
Schwarcz, R
Ottersen, OP
Citation: T. Eid et al., Ultrastructure and immunocytochemical distribution of GABA in layer III ofthe rat medial entorhinal cortex following aminooxyacetic acid-induced seizures, EXP BRAIN R, 125(4), 1999, pp. 463-475
Authors:
Fornstedt-Wallin, B
Lundstrom, J
Fredriksson, G
Schwarcz, R
Luthman, J
Citation: B. Fornstedt-wallin et al., 3-hydroxyanthranilic acid accumulation following administration of the 3-hydroxyanthranilic acid 3,4-dioxygenase inhibitor NCR-631, EUR J PHARM, 386(1), 1999, pp. 15-24
Authors:
Poeggeler, B
Pappolla, MA
Hardeland, R
Rassoulpour, A
Hodgkins, PS
Guidetti, P
Schwarcz, R
Citation: B. Poeggeler et al., Indole-3-propionate: a potent hydroxyl radical scavenger in rat brain, BRAIN RES, 815(2), 1999, pp. 382-388